Acute and Subacute Ischemic Stroke—A Review of Temperature, Blood Pressure and Glycemic Management

T he treatment of ischemic stroke is often divided between acute interventions (endovascular therapy, intravenous tissue plasminogen activator [IV tPA]) and long-term secondary prevention (modifying risk factors, antithrombotic therapy, etc.). There is great variability between practitioners in the medical management of stroke during hospitalization, in part because of confusing and contradictory results in the literature. Temperature management and therapeutic hypothermia is discussed in this review. In regards to blood pressure targets, while permissive hypertension is often recognized as a beneficial strategy in acute stroke, blood pressure reduction is essential for secondary stroke prevention. We review the literature regarding optimal timing of different blood pressure goals. Finally, the limited literature regarding glycemic control in ischemic stroke patients is discussed.

• Publication year

  2016

• Venue

  US neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17925/USN.2016.12.02.105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Blood Pressure in Acute Ischemic Stroke - Treat or Leave?

  2016cited by this paper
• The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study

  2015cited by this paper
• Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial

  2015cited by this paper
• European Stroke Organisation (ESO) Guidelines for the Management of Temperature in Patients with Acute Ischemic Stroke

  2015influential reference
• Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial.

  2014cited by this paper
• Endovascular Therapeutic Hypothermia for Acute Ischemic Stroke: ICTuS 2/3 Protocol

  2014cited by this paper
• EuroHYP-1: European Multicenter, Randomized, Phase III Clinical Trial of Therapeutic Hypothermia plus Best Medical Treatment vs. Best Medical Treatment Alone for Acute Ischemic Stroke

  2014cited by this paper
• Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke

  2013cited by this paper
• Association of Hypertension With Stroke Recurrence Depends on Ischemic Stroke Subtype

  2013cited by this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cited by this paper
• Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

  2013cited by this paper
• Acute Hypertensive Response Management in Patients with Acute Stroke

  2013cited by this paper
• The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

  2012cited by this paper
• Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke: Results From the Randomized INSULINFARCT Trial

  2012cited by this paper
• The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

  2011cited by this paper
• Blood Pressure Management in Acute Stroke: Does the Scandinavian Candesartan Acute Stroke Trial (SCAST) Resolve All of the Unanswered Questions?

  2011cited by this paper
• Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management

  2010cited by this paper
• Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.

  2010cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• Glucose Regulation in Acute Stroke Patients (GRASP) Trial: A Randomized Pilot Trial

  2009cited by this paper
• Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

  2007cited by this paper
• Blood Pressure Changes During the Initial Week After Different Subtypes of Ischemic Stroke

  2006cited by this paper
• High blood pressure in acute stroke and subsequent outcome: a systematic review.

  2004cited by this paper
• Re: Evaluation of acute candesartan cilexetil therapy in stroke survivors.

  2003cited by this paper
• Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

  2003cited by this paper
• The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

  2003cited by this paper
• Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

  2002cited by this paper
• Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size

  2002cited by this paper
• Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study

  2002cited by this paper
• Timing for fever-related brain damage in acute ischemic stroke.

  1998cited by this paper

• No citing papers are available for this paper.